ICPACT is a collaborative platform that aims to integrate ACT researchers and institutions to advance pediatric ACT research.

The new Chairperson, Camila M. M. Daiggi, organized the international workshop at the Boldrini Center in November 2024 sponsored by CNRS-IPMC (PI Enzo Lalli) and launched "The Stage II Project" at the Boldrini Research Center (Campinas – SP, Brazil) with the REDCap Boldrini system. She is also supporting other projects (pre-clinical research, clinics, genetics, pathology, epidemiology, etc).

Next Meeting Agenda

Dear All

The link for the next Meeting on April 4h (Friday), 2025 at 6PM (18:00, Curitiba) is HERE

Our agenda will include (no more than 75 minutes):

Changes in the ICPACT hot site;
A summary of the stage II project in Campinas, Curitiba, and Florianópolis (Bonald);
The Redcap (questionnaire) for the stage II project (Camila);
Present status of the future “Association of TP53 p.R337H families” (joining forces from Campinas and Curitiba);
The ICPACT leadership: from Bonald (2023-2024) to Camila (2025)… and Emília…;
An interesting pACC case (Raul C. Ribeiro);
Other important issues.

Camila M. M. Daiggi, MD
Centro Infantil Boldrini, Campinas
ICPACT-GM Chairperson (2025)

Bonald C. Figueiredo, MD., PhD
ICPACT-GM Vice-Coordinator (2025)

Disclaimer

"The information on this website is provided for informational purposes only by adrenocortical tumor researchers, and should not take the place of the advice or recommendations of your physician. Users should be aware that by accessing and using these web pages, users assume the risk that the information and documentation contained on these web pages may be offensive, inaccurate, and/or incomplete, and/or may not meet the needs and requirements of the user. The entire risk as to the use of this website is assumed by the User. ICPACT shall not be liable for any damages suffered by the users of this site, or documentation found on this website.”